Aurora Cannabis posts profit with 87% EBITDA growth, shares jump 11%: Is it too late to invest?

August 07, 2024 07:40 AM PDT | By Invezz

Aurora Cannabis posts profit with 87% EBITDA growth, shares jump 11%: Is it too late to invest? — Image source: Invezz

Impressive financial turnaround

The Canadian company reported C$4.8 million in net income for the quarter, a significant turnaround from the C$20.2 million loss recorded in the same period last year.

This remarkable performance was bolstered by a 16% year-over-year increase in plant propagation revenue, which reached C$23.1 million ($16.84 million).

Consequently, Aurora’s overall revenue climbed to C$83.4 million, surpassing analysts’ expectations of C$77.6 million and the C$74.7 million reported in the previous year.

Medical cannabis: The driving force

Aurora’s medical cannabis segment experienced a robust 13.5% growth, with revenues reaching C$47.2 million.

This growth offset a 10% decline in consumer cannabis revenue, which fell to C$11.5 million.

The strength in the medical cannabis sector also contributed to an 87% increase in adjusted EBITDA, which rose to C$4.9 million.

CEO Miguel Martin expressed confidence in the company’s ability to build on its achievements in key markets such as Germany, Australia, and the UK.

Martin highlighted Aurora’s commitment to operational excellence and strategic growth, aiming to sustain positive momentum and enhance its market position.

Positive free cash flow and fiscal discipline

Aurora Cannabis also reported a positive free cash flow of $6.5 million for the quarter.

The company attributed this success to continued strength in medical cannabis, fiscal discipline, and a solid balance sheet.

Martin emphasized these factors as critical to maintaining positive free cash flow and supporting Aurora’s long-term growth strategy.

Despite the positive earnings report, Aurora Cannabis stock is still down more than 30% from its year-to-date high in late April.

However, the stock has rallied over 100% in the past five months, reflecting growing investor confidence in the company’s turnaround efforts.

Analyst say ‘hold’

Wall Street analysts have a consensus “hold” rating on Aurora Cannabis stock, with a target price of approximately $6.34 per share.

This valuation is roughly in line with the stock’s premarket trading price on Wednesday, suggesting that the current market sentiment may consider the stock fairly valued.

Is it too late to invest?

The positive earnings report and significant growth in the medical cannabis segment have reinvigorated investor interest in Aurora Cannabis.

However, potential investors should note that the stock does not currently pay a dividend, and with its recent price surge, it may be seen as fully valued by the market.

As such, it might be prudent to carefully consider the stock’s future growth potential and market conditions before making an investment decision.

Aurora Cannabis’ return to profitability and strong performance in the medical cannabis sector marks a significant milestone for the company.

However, investors should remain cautious and consider the stock’s valuation and market dynamics before making any investment decisions.

The post Aurora Cannabis posts profit with 87% EBITDA growth, shares jump 11%: Is it too late to invest? appeared first on Invezz

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.